JP2015523346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523346A5 JP2015523346A5 JP2015516261A JP2015516261A JP2015523346A5 JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5 JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- neutropenia
- retinoid agonist
- pharmaceutical composition
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261656815P | 2012-06-07 | 2012-06-07 | |
| US61/656,815 | 2012-06-07 | ||
| PCT/US2013/044828 WO2013185105A1 (en) | 2012-06-07 | 2013-06-07 | Methods for treating neutropenia using retinoid agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015523346A JP2015523346A (ja) | 2015-08-13 |
| JP2015523346A5 true JP2015523346A5 (enExample) | 2016-06-16 |
| JP6295249B2 JP6295249B2 (ja) | 2018-03-14 |
Family
ID=49712715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516261A Expired - Fee Related JP6295249B2 (ja) | 2012-06-07 | 2013-06-07 | レチノイドアゴニストを用いた好中球減少症の治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11116738B2 (enExample) |
| EP (1) | EP2858636B1 (enExample) |
| JP (1) | JP6295249B2 (enExample) |
| KR (1) | KR102083046B1 (enExample) |
| CN (1) | CN104519879B (enExample) |
| AU (1) | AU2013270674B2 (enExample) |
| BR (1) | BR112014030279A2 (enExample) |
| CA (1) | CA2874850A1 (enExample) |
| ES (1) | ES2691493T3 (enExample) |
| MX (1) | MX365321B (enExample) |
| NZ (1) | NZ702415A (enExample) |
| RU (1) | RU2650962C2 (enExample) |
| WO (1) | WO2013185105A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11116738B2 (en) | 2012-06-07 | 2021-09-14 | Children's Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| US20160000674A1 (en) | 2013-03-15 | 2016-01-07 | Avisenna Cosmetics, Llc | Topical compositions for reducing the effects of aging |
| MX2016010699A (es) * | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
| BR112017020745A2 (pt) * | 2015-03-31 | 2018-07-17 | Syros Pharmaceuticals Inc | métodos de estratamento de pacientes para tratamento com agonistas de receptor-a de ácido retinoico. |
| US9868994B2 (en) | 2016-04-08 | 2018-01-16 | Syros Pharmaceuticals, Inc. | Methods of stratifying patients for treatment with retinoic acid receptor-α agonists |
| WO2018067946A1 (en) * | 2016-10-06 | 2018-04-12 | Syros Pharmaceuticals, Inc. | Methods of treating patients with a retinoic acid receptor-alpha agonist and an anti-cd38 antibody |
| WO2019147187A1 (en) * | 2018-01-26 | 2019-08-01 | Agency For Science, Technology And Research | Neutrophil subtypes |
| CN113969261B (zh) * | 2020-07-06 | 2024-04-09 | 苏州市立医院(北区) | 三步法快速测定中性粒细胞趋化的方法 |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
| FI131561B1 (en) * | 2023-12-28 | 2025-06-30 | Faron Pharmaceuticals Oy | CLEVER-1 INHIBITOR TO PROMOTE HEMATOLOGICAL RECOVERY WHEN USING CHEMOTHERAPY |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691196A (en) | 1992-12-31 | 1997-11-25 | American Cyanamid Company | Recombinant nucleic acid containing a response element |
| US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| AU5611398A (en) | 1996-12-19 | 1998-07-15 | American Cyanamid Company | Method of treating or inhibiting neutropenia |
| DE60125381T2 (de) | 2000-09-08 | 2007-04-12 | Massachusetts Institute Of Technology, Cambridge | Zusammensetzungen und verfahren mit analogen von g-csf |
| US7119061B2 (en) | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| AU2004238146A1 (en) | 2003-05-16 | 2004-11-25 | Kyowa Hakko Kogyo Co., Ltd. | Preventive and/or remedy for diseases accompanied by tissue destruction |
| EP1621191A1 (en) | 2004-07-29 | 2006-02-01 | Werner Bollag | Treatment of inflammatory diseases by RXR Antagonists |
| BRPI0514343A (pt) | 2004-08-13 | 2008-06-10 | Anormed Inc | combinações de quimiocinas para mobilizar células progenitoras/tronco |
| DE602005022939D1 (de) | 2004-12-02 | 2010-09-23 | Venus Remedies Ltd | Zusammensetzungen zur bekämpfung von beta-lactamase-vermittelter antibiotischer resistenz mittels beta-lactamase-hemmern für injektionen |
| US20090111786A1 (en) | 2004-12-03 | 2009-04-30 | Glass Christopher K | Compounds that Prevent Macrophage Apoptosis and Uses Thereof |
| WO2007136653A2 (en) | 2006-05-16 | 2007-11-29 | Vitae Pharmaceuticals, Inc. | Use of a rar antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects |
| EP2143428B1 (en) | 2007-03-30 | 2015-11-04 | TMRC Co., Ltd. | Tamibarotene capsule preparation |
| WO2009070844A1 (en) * | 2007-12-06 | 2009-06-11 | Csl Limited | Method of inhibition of leukemic stem cells |
| EP2604702B1 (en) | 2008-09-05 | 2015-07-01 | The University of Chicago | Methods for direct detection of DNA damage |
| CN102612371B (zh) | 2009-10-19 | 2014-03-19 | 莱拉营养食品有限公司 | 含有多聚乙酰的提取物，分馏物和混合物及它们的应用 |
| RU2446173C1 (ru) | 2010-08-13 | 2012-03-27 | Зао "Биокад" | Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе |
| CN102380090A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
| EP2673358B1 (en) | 2011-02-08 | 2019-01-09 | FUJIFILM Cellular Dynamics, Inc. | Hematopoietic precursor cell production by programming |
| WO2013169864A2 (en) | 2012-05-08 | 2013-11-14 | Lycera Corporation | TETRAHYDRO[1,8]NAPHTHYRIDINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORƴ AND THE TREATMENT OF DISEASE |
| US11116738B2 (en) | 2012-06-07 | 2021-09-14 | Children's Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| DE102012011766B3 (de) | 2012-06-15 | 2013-12-19 | Voith Patent Gmbh | Getriebeeinheit |
| CN104758922A (zh) | 2014-01-03 | 2015-07-08 | 上海泽生科技开发有限公司 | 纽兰格林制剂的配方 |
| MX2016010699A (es) | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
-
2013
- 2013-06-07 US US14/405,141 patent/US11116738B2/en active Active
- 2013-06-07 CN CN201380041537.6A patent/CN104519879B/zh not_active Expired - Fee Related
- 2013-06-07 BR BR112014030279A patent/BR112014030279A2/pt not_active Application Discontinuation
- 2013-06-07 KR KR1020157000014A patent/KR102083046B1/ko not_active Expired - Fee Related
- 2013-06-07 RU RU2014153988A patent/RU2650962C2/ru not_active IP Right Cessation
- 2013-06-07 ES ES13800873.5T patent/ES2691493T3/es active Active
- 2013-06-07 JP JP2015516261A patent/JP6295249B2/ja not_active Expired - Fee Related
- 2013-06-07 AU AU2013270674A patent/AU2013270674B2/en not_active Ceased
- 2013-06-07 CA CA2874850A patent/CA2874850A1/en not_active Abandoned
- 2013-06-07 NZ NZ702415A patent/NZ702415A/en not_active IP Right Cessation
- 2013-06-07 MX MX2014014930A patent/MX365321B/es active IP Right Grant
- 2013-06-07 EP EP13800873.5A patent/EP2858636B1/en not_active Not-in-force
- 2013-06-07 WO PCT/US2013/044828 patent/WO2013185105A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015523346A5 (enExample) | ||
| JP2013533858A5 (enExample) | ||
| JP2019519519A5 (enExample) | ||
| JP2016535786A5 (enExample) | ||
| JP2014510729A5 (enExample) | ||
| JP2015529225A5 (enExample) | ||
| JP2012046518A5 (enExample) | ||
| JP2017512193A5 (enExample) | ||
| JP2012121878A5 (enExample) | ||
| RU2014153988A (ru) | Способы лечения нейтропении с применением ретиноидных агонистов | |
| JP2009298801A5 (enExample) | ||
| MA38144A1 (fr) | Compositions et procédés pour le traitement de protéinopathies | |
| JP2009544279A5 (enExample) | ||
| JP2008535821A5 (enExample) | ||
| JP2012144574A5 (enExample) | ||
| UA118255C2 (uk) | Композиція, яка містить антитіло до cd38 і леналідомід | |
| MX2009006066A (es) | Tratamiento de cerdos con el antigeno pcv. | |
| JP2012180381A5 (enExample) | ||
| JP2011157378A5 (enExample) | ||
| JP2018505882A5 (enExample) | ||
| JP2012522010A5 (enExample) | ||
| JP2016516074A5 (enExample) | ||
| Chen et al. | Control of methicillin-resistant Staphylococcus aureus pneumonia utilizing TLR2 agonist Pam3CSK4 | |
| JP2017530130A5 (enExample) | ||
| JP2020507587A5 (enExample) |